GreyZone commented on a stock · Jan 20, 2022 09:16

Concept proof agreement.

$DISA (532.SG)$
Singapore - January 20, 2022 - Disa Digital Safety Pte. Ltd. has signed a concept proof agreement.
Through its 40% joint venture with Digital Life Line Pte. Ltd. ("DLL"), located in Singapore,
testing the scalability of its patents with two major private medical care service providers in Singapore.
The pending implementation of the Automated Antigen Rapid Testing ("ART") system ("Automated Machine") will be in February 2022.
2022.
The Automated Machine speeds up the entire ART process, enabling service providers to
Provide more tests in a shorter time. Automation will also enable our partners to
Overcome the problem of labor shortage. Digitization will also help address the increasingly growing
Given the rapid spread of the Omicron variant, ART testing volume.
Automated machines can be deployed in dormitories, MICE, airports, train stations, hotels,
schools, sports stadiums, etc.
"We are excited to test our technology in Singapore. Through collaboration with medical care institutions
service providers, we hope to expand this automated system within the region. The automated system
can be used in any type of horizontal flow care point, not limited to COVID-19," said the gentleman.
Eddie Chng, Managing Director and Chief Executive Officer of DLL.
DLL has obtained a license for the saliva-based ART kit IP from Duke-NUS Medical School and SingHealth.
The kit is called Parallel Amplification Saliva Portable Instant Test (PASPORT), using
Nanoparticles bind to viruses and unique. It also adds a second type of nanoparticles,
It also adds a second type of nanoparticles that amplifies the signal when combined with the first set of nanoparticles. This allows for testing using PASPORT.
The automated machine requires users to register by scanning their ID card or passport at the information kiosk.
Users are then asked to scan the unique QR code on the ART kit on the automated machine.
The unique QR code on the ART package on the automated machine.
Assign the unique ART suite identifier to the user for tracking and tracing.
The user will perform the test in front of the automated machine.
Follow the test steps shown on the screen.
Automated machine. Then the user can insert the ART tape into the automated machine without waiting for the test results.
The entire process is video recorded and does not exceed 5 minutes per user. The automated machine takes photos of the ART tape and sends the results automatically.
The result. The whole process is video recorded and does not exceed.
The entire process is video recorded and does not exceed 5 minutes per user. The automated machine takes photos of the ART tape and sends the results automatically.
ART tape and results are automatically sent.
Send the test results to the rightful owner in digital format within 15 to 20 minutes after the test.
Complete.
Each automated machine can process approximately 10 to 15 tests per hour.
Running 24 hours a day. With the use of automation, ART tests can be processed faster.
Video recording ensures the authenticity of the tests.
Most importantly, all ART test results cannot be tampered with, as the ART cassette tape must be inserted into the automated machine before the results.
Ensure that the ART test results cannot be tampered with, as the ART cassette tape must be inserted into the automated machine before the results.
The ART cassette tape must be inserted into the automated machine before the results.
Appeared.

The Automated Machine speeds up the entire ART process, enabling service providers to
Provide more tests in a shorter time. Automation will also enable our partners to
Overcome the problem of labor shortage. Digitization will also help address the increasingly growing
Given the rapid spread of the Omicron variant, ART testing volume.
Automated machines can be deployed in dormitories, MICE, airports, train stations, hotels,
schools, sports stadiums, etc.
"We are excited to test our technology in Singapore. Through collaboration with medical care institutions
service providers, we hope to expand this automated system within the region. The automated system
can be used in any type of horizontal flow care point, not limited to COVID-19," said the gentleman.
Eddie Chng, Managing Director and Chief Executive Officer of DLL.
DLL has obtained a license for the saliva-based ART kit IP from Duke-NUS Medical School and SingHealth.
The kit is called Parallel Amplification Saliva Portable Instant Test (PASPORT), using
Nanoparticles bind to viruses and unique. It also adds a second type of nanoparticles,
connecting the first group of nanoparticles to amplify the signal. This makes using PASPORT for testing more sensitive in detecting and marking the virus, and allows it to be used at any time of the day, even after eating or drinking,
without affecting the sensitivity of the test. Compared to
Other ART, the amplification agent PASPORT is very sensitive. In a clinical study,
Involving over 100 participants at SGH, PASPORT has shown sensitivity in detecting the virus.
Compared with the gold standard PCR test, PASPORT has a specificity of 97% and sensitivity of 90.6%. This invention
was reviewed and published by Microchimica Acta* in November 2021.

*Microchimica Acta was founded by Fritz Pregl in 1937. It is a monthly peer-reviewed scientific
journal published by Springer Nature.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

21K Views

Comment

GreyZone

Followers

Following

Visitors